Merck KGaA (XTER:MRK) EBIT per Share : €8.78 (TTM As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Merck KGaA EBIT per Share?

Merck KGaA's EBIT per Share for the three months ended in Dec. 2023 was €1.56. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €8.78.

During the past 12 months, the average EBIT per Share Growth Rate of Merck KGaA was -24.70% per year. During the past 3 years, the average EBIT per Share Growth Rate was 8.40% per year. During the past 5 years, the average EBIT per Share Growth Rate was 18.40% per year. During the past 10 years, the average EBIT per Share Growth Rate was 8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Merck KGaA's EBIT per Share or its related term are showing as below:

XTER:MRK' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -10.5 Med: 8.1 Max: 43.4
Current: 8.4

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Merck KGaA was 43.40% per year. The lowest was -10.50% per year. And the median was 8.10% per year.

XTER:MRK's 3-Year EBIT Growth Rate is ranked better than
51.41% of 852 companies
in the Drug Manufacturers industry
Industry Median: 7.6 vs XTER:MRK: 8.40

Merck KGaA's EBIT for the three months ended in Dec. 2023 was €679 Mil.

Merck KGaA EBIT per Share Historical Data

The historical data trend for Merck KGaA's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA EBIT per Share Chart

Merck KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

5.09

6.94

9.65

10.40

8.75

Merck KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															1.97	2.48	2.40	2.35	1.56

Merck KGaA EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Merck KGaA's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	3805	/	434.778
=	8.75

Merck KGaA's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	679	/	435.422
=	1.56

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €8.78

Merck KGaA (XTER:MRK) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Merck KGaA EBIT per Share Related Terms

Thank you for viewing the detailed overview of Merck KGaA's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA (XTER:MRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (XTER:MRK) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

MKKGY:USA MKGAF:USA MRK:Italy MRKd:UK 0O14:UK MRCK:Austria

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Executives

Belén Garijo Lopez	Chair of the Executive Board
Peter Guenter	Member of the Executive Board
Dr. Matthias Heinzel	Member of the Executive Board
Dr. Marcus Kuhnert	Board of Directors